Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pulmonary Fibrosis”

2,498 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 2,498 results

Testing effectiveness (Phase 2)UnknownNCT04607928
What this trial is testing

Pirfenidone Compared to Placebo in Post-COVID19 Pulmonary Fibrosis COVID-19

Who this might be right for
Fibrotic Pulmonary Sequelae Post-COVID19 Infection
Institut d'Investigació Biomèdica de Bellvitge 148
Testing effectiveness (Phase 2)Study completedNCT01055847
What this trial is testing

Aztreonam for Inhalation (AI) in Patients With Cystic Fibrosis & P. Aeruginosa Infection

Who this might be right for
Cystic FibrosisCFLung Infection+1 more
Gilead Sciences 105
Large-scale testing (Phase 3)Study completedNCT04058353
What this trial is testing

VX-445 Combination Therapy in Cystic Fibrosis (CF) Subjects Heterozygous for F508del and a Gating or Residual Function Mutation (F/G and F/RF Genotypes)

Who this might be right for
Cystic Fibrosis
Vertex Pharmaceuticals Incorporated 271
Testing effectiveness (Phase 2)Study completedNCT01983774
What this trial is testing

Effect of Proton Pump Inhibitors on CF Pulmonary Exacerbations

Who this might be right for
Cystic Fibrosis
Columbia University 21
Early research (Phase 1)Ended earlyNCT03309358
What this trial is testing

The Safety and Tolerability of Inhaled SNSP113 in Healthy Subjects and Subjects With Stable Cystic Fibrosis

Who this might be right for
Lung DiseasesPulmonary DiseaseCystic Fibrosis+13 more
Synspira, Inc. 32
Not applicableUnknownNCT04799743
What this trial is testing

The Anti-fibrotic Therapeutic Effects of Resveratrol for Discharged COVID-19 Patients

Who this might be right for
Covid-19
Hong Kong Baptist University 30
Large-scale testing (Phase 3)Study completedNCT01897233
What this trial is testing

Study of Lumacaftor in Combination With Ivacaftor in Subjects 6 Through 11 Years of Age With Cystic Fibrosis, Homozygous for the F508del-CFTR Mutation

Who this might be right for
Cystic Fibrosis
Vertex Pharmaceuticals Incorporated 62
Post-approval studies (Phase 4)Study completedNCT00685035
What this trial is testing

Comparison of Airway Clearance Therapy in Cystic Fibrosis Using the Same VEST Therapy Device But With Different Settings

Who this might be right for
Cystic Fibrosis
University of Minnesota 17
Testing effectiveness (Phase 2)Ended earlyNCT00581997
What this trial is testing

QAX576 in Patients With Pulmonary Fibrosis Secondary to Systemic Sclerosis

Who this might be right for
Pulmonary Fibrosis Secondary to Systemic Sclerosis
Novartis Pharmaceuticals 8
Not applicableStudy completedNCT02700243
What this trial is testing

Increase Tolerance for Exercise and Raise Activity Through Connectedness Trial

Who this might be right for
Cystic Fibrosis
Boston Children's Hospital 40
Not applicableStudy completedNCT01150591
What this trial is testing

Microaspiration in Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis
University of California, San Francisco 20
Large-scale testing (Phase 3)Study completedNCT06037408
What this trial is testing

The Effect of N115 on Coughing in IPF Patients

Who this might be right for
Idiopathic Pulmonary Fibrosis
Cellular Sciences, inc. 50
Testing effectiveness (Phase 2)Study completedNCT01136174
What this trial is testing

Safety and PK Study of BIBF 1120 in Japanese Patients With IPF

Who this might be right for
Idiopathic Pulmonary Fibrosis
Boehringer Ingelheim 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT04482595
What this trial is testing

BIO 300 Oral Suspension in Previously Hospitalized Long COVID Patients

Who this might be right for
COVID-19Long COVIDPulmonary Fibrosis+1 more
Humanetics Corporation 50
Not applicableStudy completedNCT03411876
What this trial is testing

Effects of Oxymizer Pendant Cannula Versus Conventional Nasal Cannula During Endurance Shuttle Walk Tests in Hypoxemic Patients With Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary FibrosisHypoxemia
Klaus Kenn 22
Large-scale testing (Phase 3)Study completedNCT04235140
What this trial is testing

Long-term Safety of Lumacaftor/Ivacaftor in Participants With Cystic Fibrosis Who Are Homozygous for F508del and 12 to <24 Months of Age at Treatment Initiation

Who this might be right for
Cystic Fibrosis
Vertex Pharmaceuticals Incorporated 52
Not applicableStudy completedNCT01150721
What this trial is testing

Comparing Expectorated and Induced Sputum and Pharyngeal Swabs for Cultures, AFB Smears, and Cytokines in Pulmonary Nontuberculous Mycobacterial Infection

Who this might be right for
Mycobacterium Infections, Non-tuberculous
National Institutes of Health Clinical Center (CC) 177
Testing effectiveness (Phase 2)Temporarily pausedNCT03756922
What this trial is testing

A DDI Study of FDL169 and FDL176 in Healthy Subjects

Who this might be right for
Cystic Fibrosis
Flatley Discovery Lab LLC 78
Not applicableUnknownNCT05663255
What this trial is testing

Effectiveness of CFTR Modulators According to Co-therapy

Who this might be right for
Cystic Fibrosis
Hospices Civils de Lyon 1,990
Not applicableStudy completedNCT03117764
What this trial is testing

1STST and Muscle Weakness in CF Patients

Who this might be right for
Cystic Fibrosis
Cliniques universitaires Saint-Luc- Université Catholique de Louvain 81
Load More Results